Cite
HARVARD Citation
Mostafid, A. et al. (2020). CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin‐C vs surgical management in low‐risk non‐muscle‐invasive bladder cancer. BJU international. pp. 817-826. [Online].